+91 789 2456 581 | info@nckpharma.com

Please sign in first

Username

Password

Lost Your Password?

Not a member?

Please simply create an account before buying/booking any courses.

Create an account for free!

Home
- About Us
- Contact
NCK services
Course List
Admission
Corporate Training
Knowledge Base

Home
- About Us
- Contact
NCK services
Course List
Admission
Corporate Training
Knowledge Base

Tag

Cipla

Cipla – Roche Deal – Cipla will promote and distribute Roche’s tocilizumab and Syndyma in India

Posted on28 Feb 2018

TagsBevacizumab, Cipla, Roche, Syndyma, tocilizumab

Comments0

Cipla Ltd and Roche Pharma India has entered an agreement under which Cipla will promote and distribute tocilizumab and Syndyma, the 2nd...

Case Study: Cipla Health’s Nicotex Nicotine patches launch in Indian Market

Posted on22 Aug 2017

Tags2baconil, Cipla, Nicotex, Nicotex Nicotine patches, Rusan Healthcare India’s first fully indigenous nicotine patch 2baconil™

Comments0

Cipla Health, an arm Cipla with a focus on consumer healthcare products, launched Nicotex Nicotine patches. Nicotex Nicotine patch is a skin/transdermal...

Cipla to acquire pharmaceuticals company Anmarate Pty Ltd

Posted on06 Apr 2017

Tagsacquisition in pharma, Cipla

Comments0

Drugmaker Cipla Ltd’s South African arm has agreed to acquire pharmaceuticals company Anmarate Pty Ltd for ZAR 26.25 million ($1.8 million) in...

Cipla’s Subsidiary forms a JV in Iran

Posted on16 Dec 2016

TagsCipla, pharma business expansion

Comments0

Cipla Holding B.V., a wholly owned subsidiary of the company in Netherlands, Cipla Netherlands, has entered into a joint venture agreement with...

Allergan’s acquisition of Chase Pharmaceuticals – Cipla divests its 16.7% stake in Chase Pharmaceuticals Corp

Posted on24 Nov 2016

TagsAllergan, Chase Pharmaceutical, Cipla

Comments0

Allergan plc announced acquisition of Chase Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company focused on the development of improved treatments for neurodegenerative disorders...

Intas Pharma to acquire Teva’s UK, Ireland generics businesses

Posted on11 Oct 2016

Tagsacquisistion in pharma, Cipla, Intas Pharma

Comments0

Intas Pharmaceuticals Ltd agreed to buy Actavis UK Ltd and Actavis Ireland Ltd from Israeli generic drug maker Teva Pharmaceutical Industries Ltd...

Biocon launched Gilead Sciences’ Hepatitis C drug – CIMIVIR-L in India

Posted on25 Dec 2015

TagsBiocon, Biocon launched Gilead Sciences' Hepatitis C drug - CIMIVIR-L in India, CIMIVIR-L, Cipla, Gilead Sciences, Hepcvir-L

Comments0

BIopharmaceutical company Biocon on Thursday said it has launched a generic version of Gilead Sciences’ Hepatitis C drug, Harvoni, in India. The...

Top 10 Generic Pharma companies by revenue 2014

Posted on28 Nov 2015

Tagsactavis, Aspen, Aurobindo, Cipla, DRL, Fresenius Kabi, Hospira, novartis, sandoz, Stada Arzneimittel, Teva, Top 10 Generic Pharma companies by revenue 2014

Comments0

Cipla looking to stregthen US business by acquiring Hetero’s US business

Posted on04 Sep 2015

TagsCipla, Cipla looking to stregthen US business by acquiring Hetero's US business, Hetero

Comments0

US currently contributes 8 percent to Cipla’s overall revenues and looking to strengthen further in coming years. Cipla is in advance stage...

Stempeutics gets process patent from Japan for Stempeucel

Posted on10 Jun 2015

TagsCipla, Stempeucel, Stempeutics gets process patent from Japan for stem cell-based drug

Comments0

Stempeutics Research, a firm part-owned by Cipla Ltd, said that it has won a process patent from the Japan Patent Office for...

Our Popular Courses

Pharma Product Management
Digital Pharma Marketing
Strategic Management
Regulatory Affairs
Pharma Marketing
European DRA
Sales Management
Pharmacovigilance
Production Management
ASEAN DRA
GCC DRA
Pharma Project Management
Export Documentation

Recent Articles

Insight on 2019 USFDA New Drug Approval
Insight on J&J’s TB mass awareness campaign in India
CUTX-101 of Fortress Biotech gets US FDA rare pediatric disease designation to treat Menkes disease
What is Edible security tag?
Acquisition in Pharma: Why Astellas to acquire Xyphos Biosciences?
US FDA issued CRL to ViiV Healthcare for use of cabotegravir and rilpivirine long-acting regimen for treatment of HIV
US FDA issues Complete Response Lette to Takeda’s Entyvio for maintenance therapy in adults with ulcerative colitis
What is ISO 15197:2013 certification?
Copromotion deal for Japan – Gilead and Eisai in RA therapy filgotinib
Insight on USFDA approval of Allergan’s Ubrelvy
Insight on Alteogen’s non-exclusive licensing deal for ALT-B4 to a top 10 global pharma
Pharma Strategic Deal: Astellas Pharma to acquire Audentes Therapeutics for about $3 billion
Pharma Business Development – Competency Test. Check your competency
Case study: Novartis to acquire The Medicines Company for $9.7 billion, get hold of inclisiran, a cholesterol drug
What is USFDA Purple Book? What it’s significance?
USFDA approved Pfizer’s Abrilada, a biosimilar of Humira
Pfizer’s Upjohn and Mylan merged business entity will be namea as Viatris
Bayer and Dewpoint Therapeutics co-development deal for cardiovascular and gynecological diseases
Sandoz to Acquire Japanese Biz of AGI
Selumetinib NDA Submission for Neurofibromatosis Type 1 (NF1) granted Priority Review

Course Category

KPE® – Certificate Program (1 Month)
KPE® – Certificate Program (1 Week)
KPE® – Publications / White Papers / Workshop / Others
KPE® Advance Diploma Program (1 Year Program)
KPE® Advance Diploma Program – Dual Specialization (1 Year Program)
KPE® Executive Program (1 Year Program)

Certification Courses

View our online Certification Courses.

Corporate Training

View list of courses, simulation, e-books, libararies for Pharma Corporate, Government and Regulatory Bodies.

Subscribe to NCK Newsline

Enter your email address:

Delivered by FeedBurner

Popular 1 Year Courses

KPE – C- 024 KPE’s Executive Program in Pharmaceutical Global Business
KPE-C-001 KPE’s Advance Diploma in Pharmaceutical Product Management
KPE-C-003 KPE’s Advance Diploma in Drug Regulatory Affairs
KPE-C-004 KPE’s Advance Diploma in Pharma Marketing
KPE – C- 009 KPE’s Advance Diploma in Pharmacovigilance
KPE-C-005 KPE’s Advance Diploma in Pharmaceutical Production management
KPE-C-08 KPE’s Advance Diploma in Pharmaceutical Strategic Business Management

Javascript is disabled

Javascript is disabled on your browser. Please enable it in order to use this form.

Loading

Query

First Name

Last Name

Email Address

Your Query *

Write Here

10 plus 6 equals?*

Prove you are a human

Write here

Your form has been submitted

Thank you %NAME% for the submitting your query/feedback.

Server Side Error

We faced problems while connecting to the server or receiving data from the server. Please wait for a few seconds and try again.

If the problem persists, then check your internet connectivity. If all other sites open fine, then please contact the administrator of this website with the following information.

TextStatus: undefined
HTTP Error: undefined

Processing your request

Error

Some error has occured.

Disclaimer & Privacy Policy | Terms of Use

Copyright © 2014 - 2015 All Right Reserved - NCK Pharma Solution Private Limited

This website uses cookies to improve your learning experience. Ok Privacy Policy

Privacy & Cookies Policy

Necessary Always Enabled

Scale up your Pharma knwledge to Next Level with our Free Content

Case studies & Caselets
Simulation based learning
Online self competency assessment tests

etc.